St. Jude Medical Inc. (NYSE:STJ) won pre-market approval for 2 next-generation cardiac ablation systems this month, the Therapy Cool Path Duo and Safire Blu Duo catheters.
Both ablation systems use radiofrequency energy to freeze small areas of faulty cardiac tissue in patients with typical trial flutter, a type of arrhythmia in which patients experience abnormal heart rhythms or an abnormally fast heartbeat in the upper chambers of the heart.
The numbers on pulmonary disease in the U.S are staggering – more than 203,000 people were diagnosed in 2007 alone, according to the Centers for Disease Control, which lists nearly 160,000 lung cancer deaths for that year.
Add in other pulmonary afflictions like chronic obstructive pulmonary disease (126,000 deaths in 2005, according to the CDC) and the numbers pass from staggering to mind-boggling.
Boston Scientific (NYSE:BSX) inked an exclusive deal with Catheter Robotics Inc. to distribute the CRI Amigo remote catheter system in Europe.
BSX said it plans to market the system, which allows doctors to remotely control variety of catheter-based devices during treatment of arrhythmias, in Austria, Belgium, France, Germany, Luxembourg, The Netherlands, Portugal, Spain and Switzerland.
FFR is a measurement of the severity of coronary artery blockage. St. Jude’s wireless device links with cardiac catheterization lab systems to track and log FFR measurements during coronary intervention procedures such as angiography.
MASSDEVICE ON CALL — Your car may be able to monitor your physical and mental health as you travel, thanks to a steering wheel developed by Germany’s BMW Group in collaboration with university researchers.
The steering wheel incorporates sensors that monitor vital signs and stress levels using metrics like heart rate and blood oxygen saturation, and take measures to reduce distractions or slow down the vehicle.
George LeMaitre, chairman & CEO of the vascular device firm that bears his name, told analysts on a conference call that LeMaitre Vascular (NSDQ:LMAT) has two new products it expects to launch during the fourth quarter.
The Burlington, Mass.-based company is in the last stages of post-approval trials for the devices – the UnBalloon and an over-the-wire device used to excise heart valves – LeMaitre said during a call to discuss LMAT’s third-quarter numbers.
Hospital group purchasing organizations Novation and Premier signed new contracts this week, covering patient monitoring solutions, intra-aortic balloon catheters and pumps.
Novation awarded a three-year contract to Spacelabs Healthcare, a subsidiary of OSI Systems Inc. (NSDQ:OSIS), for patient monitoring and connectivity solutions.
C.R. Bard (NYSE:BCR) is set to announce the purchase of Clearstream Technologies, an Ireland-based developer of catheters used in angioplasty procedures, according to a report by the U.K.-based Sky news service.
Murray Hill, N.J.-based Bard will pay a “price well in excess of today’s closing share price of 45.89p,” according to Sky.